Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
16.07.24
/
50%
€0.27
Target price
16.07.25
€68.81
Performance (%)
-15.56%
Price
19.09.24
€6.40
Summary
This prediction is currently active. The price of Galmed Pharmaceuticals Ltd. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.56%. This prediction currently runs until 16.07.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $72.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.24
28.08.24
28.08.24
€69.28
28.08.25
28.08.25
2589.08%
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
1827.71%
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.36
08.05.24
08.05.24
€58.61
08.05.25
08.05.25
1667.96%
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
2062.16%
19.09.24
19.09.24